These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21739926)

  • 1. PBM effort takes cue from reform, market.
    Diamond F
    Manag Care; 2011 Jun; 20(6):52. PubMed ID: 21739926
    [No Abstract]   [Full Text] [Related]  

  • 2. Biologics trend leads pharmaceuticals.
    Manag Care; 2005 Sep; 14(9):66. PubMed ID: 16238263
    [No Abstract]   [Full Text] [Related]  

  • 3. Consider medicare drug benefit plan for healthcare reform.
    Henschke MR
    J Am Osteopath Assoc; 2002 Oct; 102(10):523-4. PubMed ID: 12401037
    [No Abstract]   [Full Text] [Related]  

  • 4. Designing an integrated drug benefit for the elderly.
    King AB; Colligen BH; Levy RA; Cohen KR
    J Am Health Policy; 1994; 4(4):41-5. PubMed ID: 10136682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicare reform opinions. Opening door to choices. Medicare reform opinions.
    Ignagni K
    Mod Healthc; 2003 Dec 22-29; 33(51):23. PubMed ID: 14723082
    [No Abstract]   [Full Text] [Related]  

  • 6. A conversation with Debra Dullinger, PharmD.
    Dullinger D
    Med Interface; 1994 Oct; 7(10):71-4. PubMed ID: 10137568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A whole new world?: pharmaceutical responses to the managed care revolution.
    Balto DA
    Food Drug Law J; 1997; 52(1):83-98. PubMed ID: 10346712
    [No Abstract]   [Full Text] [Related]  

  • 8. The case against excessive cost sharing.
    Brixner DI
    Am J Manag Care; 2006 Apr; 12(6 Suppl):S162-4; discussion S167-72; quiz S173-6. PubMed ID: 16613531
    [No Abstract]   [Full Text] [Related]  

  • 9. MCO-PBM (managed care organization-prescription benefit management) partnerships holding down drug trend.
    Alexander W
    Exec Solut Healthc Manag; 1998 Dec; 1(10):1, 4-6. PubMed ID: 10338773
    [No Abstract]   [Full Text] [Related]  

  • 10. Is the market ready for direct pharmaceutical contracting by employers?
    Giaquinta D
    Manag Care Interface; 2004 Aug; 17(8):33-4. PubMed ID: 15471109
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost not the primary factor driving drug coverage.
    Capitation Rates Data; 2000 May; 5(5):51-3. PubMed ID: 11066970
    [No Abstract]   [Full Text] [Related]  

  • 12. How well does your PBM perform?
    McCarthy R
    Bus Health; 1999 Jan; 17(1):24-9. PubMed ID: 10345211
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of randomized controlled trials in organizational decision making: a cost-minimization approach.
    Cher DJ; Maclure M
    Am J Manag Care; 2000 Aug; 6(8):894-904. PubMed ID: 11186501
    [No Abstract]   [Full Text] [Related]  

  • 14. Plans continue to raise copayments.
    Manag Care; 2005 Sep; 14(9):59. PubMed ID: 16238260
    [No Abstract]   [Full Text] [Related]  

  • 15. Tier 4 drugs and the fraying of the social compact.
    Lee TH; Emanuel EJ
    N Engl J Med; 2008 Jul; 359(4):333-5. PubMed ID: 18650510
    [No Abstract]   [Full Text] [Related]  

  • 16. Time to leave the capsule ... if you dare.
    McCarthy R
    Bus Health; 1991 Sep; 9(9):22-3, 26, 28 passim. PubMed ID: 10112859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could a Wal-Mart PBM succeed?
    Carroll J
    Manag Care; 2008 Apr; 17(4):36-8. PubMed ID: 18464572
    [No Abstract]   [Full Text] [Related]  

  • 18. Market forces driving health care reform.
    Capilouto E
    J Dent Educ; 1995 Apr; 59(4):480-3. PubMed ID: 7782549
    [No Abstract]   [Full Text] [Related]  

  • 19. Public payers foot greater pharmacy costs.
    Manag Care; 2006 Jul; 15(7):70. PubMed ID: 16898070
    [No Abstract]   [Full Text] [Related]  

  • 20. Rebates and other drug-cost issues.
    Penna P
    Manag Care Interface; 2003 May; 16(5):39-40. PubMed ID: 12789863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.